AI Noise Reduction in Phonak Hearing Aids

Mayo Clinic

Status: Enrolling

Conditions: Hearing Loss

Treatments: Device: DEEPSONIC™ Deep Sound Optimized Neural Integrated Chip Artificial intelligence-based noise reduction

Study type: Interventional

Funder types: Other

Identifiers

NCT06743295

24-009408

Details and patient eligibility

About

The purpose of this study is to determine if artificial intelligence- based noise reduction can offer objective improvement in hearing and speech perception for hearing impaired patients.

Enrollment: 500 estimated patients

Sex: All

Ages: 18 to 110 years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• Patients with hearing impairment not using hearing aids
• Individuals with hearing impairment currently using hearing aids
• Cochlear implant patients with a single-sided implant (using a hearing aid in the opposite ear)

Trial design

Primary purpose: Treatment

Allocation: Non-Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

500 participants in 2 patient groups

Hearing Aid only

Experimental group

Description:

Patients with hearing impairment who do not have a Cochlear implant

Treatment:

Device: DEEPSONIC™ Deep Sound Optimized Neural Integrated Chip Artificial intelligence-based noise reduction

Cochlear Implant with Hearing Aid

Experimental group

Description:

Patients with hearing impairment who have a single-sided implant (using a hearing aid on the opposite ear)

Treatment:

Device: DEEPSONIC™ Deep Sound Optimized Neural Integrated Chip Artificial intelligence-based noise reduction